# b-rayZ

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/b-rayz

- Industry: Healthcare IT
- Headquarters: Zurich, Switzerland
- Website: www.b-rayz.ch
- Total disclosed funding: $4.1M
- Latest round: Series A (Jul 7, 2022)
- Investors on record: 5

## About

Founded in 2019 by Andreas Boss, Cristina Rossi (CEO) and Alexander Ciritsis, and based in Zurich, Switzerland, b-rayZ AG, a spin-off of the University Hospital Zurich operates as a developer of medical software for the quality control of the radiologist in mammography. In July 2022, b-rayZ AG raised CHF 4 million in Series A funding co-led by LifeCare Partners, Protagon AG, and Convergence Partners, with participation from Eckenstein-Geigy-Stiftung, and the Swisspreneur association. 



The company creates and sells software that uses artificial intelligence (AI) to supplement radiologists' visual inspections and provide quality assurance during breast assessments. The platform provides AI-based image quality evaluation and enables the early detection of breast cancer by enabling the automatic detection of early-stage lesions in mammography and ultrasound.

## Funding rounds

- Series A, Jul 7, 2022, $4.1M — Solcon Capital, Eckenstein-Geigy-Stiftung, LifeCare Partners, Swisspreneur Syndicate, Protagon AG

## Investors

- Solcon Capital (https://capitalatlas.ai/funds/solcon-capital) — Series A
- Eckenstein-Geigy-Stiftung — Series A
- LifeCare Partners (https://capitalatlas.ai/funds/lifecare-partners) — Series A
- Swisspreneur Syndicate — Series A
- Protagon AG (https://capitalatlas.ai/funds/protagon-ag) — Series A